(4R,7R,8S)-1-methyl-8-((Z)-N-methyl-N'-((methylcarbamoyl)oxy)carbamimidoyl)-6-oxo-4,8-dihydro-1H-4,7-methanopyrazolo[3,4-e][1,3]diazepin-5(6H)-yl hydrogen sulfate

(4R,7R,8S)-1-methyl-8-((Z)-N-methyl-N'-((methylcarbamoyl)oxy)carbamimidoyl)-6-oxo-4,8-dihydro-1H-4,7-methanopyrazolo[3,4-e][1,3]diazepin-5(6H)-yl hydrogen sulfate Struktur
2531422-29-2
CAS-Nr.
2531422-29-2
Englisch Name:
(4R,7R,8S)-1-methyl-8-((Z)-N-methyl-N'-((methylcarbamoyl)oxy)carbamimidoyl)-6-oxo-4,8-dihydro-1H-4,7-methanopyrazolo[3,4-e][1,3]diazepin-5(6H)-yl hydrogen sulfate
Synonyma:
(4R,7R,8S)-1-methyl-8-((Z)-N-methyl-N'-((methylcarbamoyl)oxy)carbamimidoyl)-6-oxo-4,8-dihydro-1H-4,7-methanopyrazolo[3,4-e][1,3]diazepin-5(6H)-yl hydrogen sulfate
CBNumber:
CB511667794
Summenformel:
C12H17N7O7S
Molgewicht:
403.37
MOL-Datei:
2531422-29-2.mol

(4R,7R,8S)-1-methyl-8-((Z)-N-methyl-N'-((methylcarbamoyl)oxy)carbamimidoyl)-6-oxo-4,8-dihydro-1H-4,7-methanopyrazolo[3,4-e][1,3]diazepin-5(6H)-yl hydrogen sulfate Eigenschaften

Dichte
1.88±0.1 g/cm3(Predicted)
pka
-3.01±0.18(Predicted)

Sicherheit

(4R,7R,8S)-1-methyl-8-((Z)-N-methyl-N'-((methylcarbamoyl)oxy)carbamimidoyl)-6-oxo-4,8-dihydro-1H-4,7-methanopyrazolo[3,4-e][1,3]diazepin-5(6H)-yl hydrogen sulfate Chemische Eigenschaften,Einsatz,Produktion Methoden

(4R,7R,8S)-1-methyl-8-((Z)-N-methyl-N'-((methylcarbamoyl)oxy)carbamimidoyl)-6-oxo-4,8-dihydro-1H-4,7-methanopyrazolo[3,4-e][1,3]diazepin-5(6H)-yl hydrogen sulfate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(4R,7R,8S)-1-methyl-8-((Z)-N-methyl-N'-((methylcarbamoyl)oxy)carbamimidoyl)-6-oxo-4,8-dihydro-1H-4,7-methanopyrazolo[3,4-e][1,3]diazepin-5(6H)-yl hydrogen sulfate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate

  • (4R,7R,8S)-1-methyl-8-((Z)-N-methyl-N'-((methylcarbamoyl)oxy)carbamimidoyl)-6-oxo-4,8-dihydro-1H-4,7-methanopyrazolo[3,4-e][1,3]diazepin-5(6H)-yl hydrogen sulfate
  • 2531422-29-2
Copyright 2019 © ChemicalBook. All rights reserved